Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | VP, Finance & Accounting | March 15, 2021 | March 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date March 15, 2021 · Filed March 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 71,766 |
Ending reported balance
After 2021-03-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-03-15 · Sale · Disposed 10,912 · Balance 71,766 F1: Executed in multiple trades at prices ranging from $6.90 to $6.92 per share. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 2 · 2021-03-15 · Exercise / conversion · Acquired 12,000 · Balance 83,766 Row 3 · 2021-03-15 · Sale · Disposed 12,000 · Balance 71,766 F2: Executed in multiple trades at prices ranging from $6.91 to $6.955. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.31 · Expires 2030-02-06 | Direct | 50,980 |
Reported balance
After 2021-03-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-03-15 · Exercise / conversion · Disposed 12,000 · Balance 50,980 F3: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Executed in multiple trades at prices ranging from $6.90 to $6.92 per share. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Executed in multiple trades at prices ranging from $6.91 to $6.955. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2021 Filed Mar 16, 2021 23:45 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001127602-21-010892 · form4.xml · derivative · entry 4 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,980 Underlying: Common Stock · 12,000 shares Expires 2030-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:45 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | SaleCommon Stock | 12,000 | $6.93 | $83,100.00 |
DisclosureSEC source: 0001127602-21-010892 · form4.xml · nonDerivative · entry 3 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,766 F2 · price: Executed in multiple trades at prices ranging from $6.91 to $6.955. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:45 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 12,000 | $3.31 | $39,720.00 |
DisclosureSEC source: 0001127602-21-010892 · form4.xml · nonDerivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:45 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | SaleCommon Stock | 10,912 | $6.90 | $75,339.72 |
DisclosureSEC source: 0001127602-21-010892 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,766 F1 · price: Executed in multiple trades at prices ranging from $6.90 to $6.92 per share. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 13,997 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · derivative · entry 9 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,993 Underlying: Common Stock · 13,997 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F6 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,836 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · derivative · entry 8 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,837 Underlying: Common Stock · 8,836 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · derivative · entry 7 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · derivative · entry 6 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 10,765 | $7.19 | $77,400.35 |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · nonDerivative · entry 5 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,678 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 13,997 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · nonDerivative · entry 4 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,836 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · nonDerivative · entry 3 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · nonDerivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008775 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 24,340 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001127602-21-005838 · form4.xml · derivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,340 Underlying: Common Stock · 24,340 shares Expires 2031-02-11 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 16,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005838 · form4.xml · derivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,230 Underlying: Common Stock · 16,230 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 3,997 | $1.96 | $7,834.12 |
DisclosureSEC source: 0001127602-20-014493 · form4.xml · nonDerivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,127 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 13,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014493 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,124 F1 · kind: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · derivative · entry 9 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,673 Underlying: Common Stock · 8,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,214 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · derivative · entry 8 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,213 Underlying: Common Stock · 4,214 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · derivative · entry 7 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,270 Underlying: Common Stock · 1,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · derivative · entry 6 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 3,902 | $2.77 | $10,808.54 |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · nonDerivative · entry 5 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,862 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · nonDerivative · entry 4 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,214 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · nonDerivative · entry 3 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · nonDerivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008967 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 62,980 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001127602-20-004603 · form4.xml · derivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,980 Underlying: Common Stock · 62,980 shares Expires 2030-02-06 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 41,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004603 · form4.xml · derivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,990 Underlying: Common Stock · 41,990 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| August 02, 2019 Filed Aug 2, 2019 20:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 10,000 | $1.14 | $11,400.00 |
DisclosureSEC source: 0001127602-19-025869 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,368 Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · derivative · entry 9 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,427 Underlying: Common Stock · 4,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F7 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F7 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · derivative · entry 8 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,540 Underlying: Common Stock · 1,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · derivative · entry 7 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,075 Underlying: Common Stock · 2,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · derivative · entry 6 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 2,501 | $5.51 | $13,780.51 |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · nonDerivative · entry 5 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,368 F3 · kind: Withholding of a portion of vested shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · nonDerivative · entry 4 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · nonDerivative · entry 3 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · nonDerivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009266 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 26,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004892 · form4.xml · derivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,510 Underlying: Common Stock · 26,510 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 39,770 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001127602-19-004892 · form4.xml · derivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,770 Underlying: Common Stock · 39,770 shares Expires 2029-02-07 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:37 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $10.15 | $0.00 |
DisclosureSEC source: 0001127602-18-020694 · form4.xml · derivative · entry 3 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,428 Underlying: Common Stock · 10,000 shares Expires 2019-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/12/2010) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:37 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | SaleCommon Stock | 10,000 | $12.91 | $129,076.00 |
DisclosureSEC source: 0001127602-18-020694 · form4.xml · nonDerivative · entry 2 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,643 Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:37 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,000 | $10.15 | $101,500.00 |
DisclosureSEC source: 0001127602-18-020694 · form4.xml · nonDerivative · entry 1 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · derivative · entry 9 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,810 Underlying: Common Stock · 1,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · derivative · entry 8 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,150 Underlying: Common Stock · 2,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · derivative · entry 7 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,668 Underlying: Common Stock · 2,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 1,340 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · derivative · entry 6 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 1,805 | $8.53 | $15,396.65 |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · nonDerivative · entry 5 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,643 F2 · kind: Withholding of a portion of vested shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 1,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · nonDerivative · entry 4 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009733 · form4.xml · nonDerivative · entry 3 Tessmer James F · CIK 0001434095 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.